Probiotics, like lactic acid bacteria, are non-pathogenic microbes that exert health benefits to
the host when administered in adequate quantity. Currently, research is being conducted on …

The uncertainty of potential risks associated with micro-and nanoplastics (MNPs) are of
growing public concern. However, the diversity of MNPs in the environment makes a …

Methods The gut microbiome was analyzed via next-generation sequencing in healthy
people (n= 37) and NAFLD patients with elevated liver enzymes (n= 57). Six-week-old male …

Non-alcoholic fatty liver disease (NAFLD) is a common liver disease with a rapidly
increasing number of cases worldwide. This study aimed to evaluate the effects of …

Hypercholesteremia or high cholesterol is one of the important factors leading to
atherosclerosis and other cardiovascular diseases. The application of probiotics with …

High-fat diet (HFD) consumption is a risk factor for dyslipidemias, insulin resistance, and
arterial hypertension linked with gut dysbiosis. Probiotic administration has been suggested …

Abstract Bile Salt Hydrolase (BSH) is a bacterial enzyme (EC 3.5. 1.24) that initiates the
crucial deconjugation of bile acids (BAs), a process necessary for their transformation into …

Fruits and their processing by-products are sources of potentially probiotic strains.
Limosilactobacillus (L.) fermentum strains isolated from fruit processing by-products have …

Nutraceuticals and functional foods are considered useful tools in the management of
moderate plasmatic cholesterol levels. Natural compounds derived from plant, animal, or …

Increasing researches have considered gut microbiota as a new “metabolic organ,” which
mediates the occurrence and development of metabolic diseases. In addition, the liver is an …